PRMT5 and colorectal carcinoma: Our group and others have previously reported that overexpression of PRMT5 enhanced the proliferative, migratory, and colony-forming abilities of CRC cells, whereas knockdown or pharmacological inhibition of PRMT5 had the opposite effect, making it a highly attractive therapeutic target [1,2].